Abstract: The polymer film serves for the embedding of a medical technology product to be implanted in a human organism. The polymer film includes a polymer of natural origin being biodegradable and absorbable by the human body. The polymer film has a polymer content. The polymer film further includes two antimicrobial active ingredients having a different mechanism of action and the polymer film has a total active-ingredient content. The ratio of the total active-ingredient content to the polymer content is at least 15%. The polymer content is greater than the total active-ingredient content. The polymer film is bendable and modulable and uninterrupted. The polymer forms a polymer matrix in which the antimicrobial active ingredients are embedded in a homogeneously distributed manner. The polymer film has, for each of the antimicrobial active ingredients, an individual active-ingredient content deviating from one another by at most 20%.

Abstract: A motor vehicle has a plurality of battery modules for storing electrical energy in the region of an underbody of a passenger compartment of the motor vehicle. The underbody is delimited on each of the two sides by a side sill. As viewed in the vehicle longitudinal direction, at least two battery modules are arranged adjacent to each other between the side sills, wherein the battery modules adjoin the respective side sills and a deformation element is arranged in each case between the adjacent battery modules. The battery modules are protected against damage in the event of a side crash.

Abstract: A motor vehicle has a plurality of battery modules for storing electrical energy in the region of an underbody of a passenger compartment of the motor vehicle. The underbody is delimited on each of the two sides by a side sill. As viewed in the vehicle longitudinal direction, at least two battery modules are arranged adjacent to each other between the side sills, wherein the battery modules adjoin the respective side sills and a deformation element is arranged in each case between the adjacent battery modules. The battery modules are protected against damage in the event of a side crash.

Abstract: By combining at least two different vehicle front end modules and passenger cell modules, at least two groups of motor vehicles belonging to different vehicle categories can be formed. For this purpose, the two vehicle front end modules feature different distances between the engine mounts, and the two passenger cell modules feature different distances between the front seats. The individual variants of each of the four modules are designed as identical parts and are manufactured in uniform deep-drawing dies for each module.

Abstract: By combining at least two different vehicle front end modules and passenger cell modules, at least two groups of motor vehicles belonging to different vehicle categories can be formed. For this purpose, the two vehicle front end modules feature different distances between the engine mounts, and the two passenger cell modules feature different distances between the front seats. The individual variants of each of the four modules are designed as identical parts and are manufactured in uniform deep-drawing dies for each module.

Abstract: Disclosed is a multi-chamber applicator comprising an aqueous gelatin solution and an aqueous cross-linking agent solution in separate chambers.

Abstract: A component connection arrangement and a method of connecting components is provided in which a first component having a projecting male fixing element is connected to a second component in a friction-locking manner by a sleeve-like or cap-like clip element snapped on the male fixing element, with the clip element being clamped between the male fixing element and a female fixing element provided on or in the second component.

Abstract: The invention relates to the use of gelatin and a cross-linking agent to provide a medical glue which forms a cross-linked gelatin gel in an area of application of the human or animal body. According to the invention, (i) the gelatin and the cross-linking agent are mixed with each other to form the cross-linking medical glue which is then administered to the area of application; or (ii) the gelatin and the cross-linking agent are made available in separate form and are administered, simultaneously or one after the other, to the area of application while forming the cross-linking medical glue.

Abstract: A component connection arrangement and a method of connecting components is provided in which a first component having a projecting male fixing element is connected to a second component in a friction-locking manner by a sleeve-like or cap-like clip element snapped on the male fixing element, with the clip element being clamped between the male fixing element and a female fixing element provided on or in the second component.

Abstract: Disclosed is a multi-chamber applicator comprising an aqueous gelatin solution and an aqueous cross-linking agent solution in separate chambers.

Abstract: A therapeutic composition comprising gelatin and a cross-linking agent, for use in biological regenerative methods, which composition can be administered to a target area of the body while ensuring that the suspended cells and/or the growth factors remain in the target area of the body and at the same time eliminating the need for the patient to maintain the treated body area immobilized for unreasonable periods, is disclosed. A method is also disclosed, wherein (i) the gelatin and the cross-linking agent are mixed with each other to form the cross-linking therapeutic composition which is then administered to the target area; or (ii) the gelatin and the cross-linking agent are made available in separate form and are administered, simultaneously or one after the other, to the target area while forming the cross-linking therapeutic composition.

Abstract: The shaped body is intended for introduction into an alveolar space or into another bone defect location. A composite material with at least a first material component in the form of a collagen material and a second material component in the form of a bone replacement material is provided for the shaped body. The collagen material forms a matrix, in which the bone replacement material is embedded, distributed non-homogeneously, so that a local collagen proportion based on any desired part volume of 30 mm3 is at least 10% everywhere and a global collagen proportion based on the total volume is in the range between 30% and 95%. The shaped body is compressible. A local bone replacement proportion based, in each case, on a part volume of 30 mm3 has its maximum value at an edge face and decreases inwardly proceeding from the edge face, a BRM zone provided with bone replacement material extending into the interior proceeding from the edge face.

Abstract: In order to provide a non-woven fiber fabric, in particular, in the form of a flat material or as part of a flat material which can be used as a biodegradable material in medicine, in particular, as an implant or carrier material for living cells (tissue engineering) but also a non-woven fiber fabric which can be used in food technology in a variety of applications, in particular, as a preliminary product for foods, a non-woven fiber fabric is provided containing fibers consisting of a gelatin material, wherein the thickness of the fibers is on average 1 to 500 ?m and wherein the non-woven fiber fabric has a plurality of areas, at which two or more fibers merge into one another without any phase boundary.

Abstract: The aim of the invention is to provide a nerve guide that allows the axons to develop fairly freely during regeneration. For this purpose, the nerve guide is produced based on a shaped body from a cross-linked, resorbable, gelatin-based material. The shaped body is a tubular hollow body having a wall with an exterior surface and an interior surface, which wall defines a lumen. The nerve guide comprises a semipermeable layer surrounding the lumen.

Abstract: In order to provide a vascular stent, with which the risk of restenosis is reduced without having to use anti-proliferative active substances, there is proposed a carrier of a dimensionally stable material, as well as one or more layers, which are disposed at least in sections on the carrier, of a material based on crosslinked gelatin that is resorbable under physiological conditions, wherein the adhesion between the carrier and the layer and/or between individual layers can be neutralised.

Abstract: The present invention relates to a method for the production of a quickly wettable material containing natural hydrocolloid in the form of a shaped body, in which a material containing natural hydrocolloid in the form of a shaped body is exposed to a plasma.

Abstract: The present invention relates to a composite biomaterial and a process for producing a composite biomaterial with controlled release of active ingredients, comprising a three-dimensional polymer-based support structure, and a polymer-based matrix structure. The active ingredients are in this case incorporated into the composite biomaterial via the matrix structure, and the composite biomaterial is obtainable by introducing the matrix structure into the support structure. The active ingredients may in this case be incorporated for example adhesively, via specific binder molecules or via enzyme-labile linker molecules via the matrix structure into the composite biomaterial.

Abstract: To provide an angiogenesis-promoting substrate which can be easily and cost-effectively produced, it is proposed that the substrate comprise a non-porous shaped body formed from a gelatin-containing material which is insoluble and resorbable under physiological conditions.

Abstract: In order to provide a vascular stent, with which the risk of restenosis is reduced without having to use anti-proliferative active substances, there is proposed a carrier of a dimensionally stable material, as well as one or more layers, which are disposed at least in sections on the carrier, of a material based on crosslinked gelatin that is resorbable under physiological conditions, wherein the adhesion between the carrier and the layer and/or between individual layers can be neutralised.

Abstract: In order to provide a non-woven fiber fabric, in particular, in the form of a flat material or as part of a flat material which can be used as a biodegradable material in medicine, in particular, as an implant or carrier material for living cells (tissue engineering) but also a non-woven fiber fabric which can be used in food technology in a variety of applications, in particular, as a preliminary product for foods, a non-woven fiber fabric is provided containing fibers consisting of a gelatin material, wherein the thickness of the fibers is on average 1 to 500 ?m and wherein the non-woven fiber fabric has a plurality of areas, at which two or more fibers merge into one another without any phase boundary.